Study #2020-0508
COVID-19: Well-being in cancer patients with neuropathy who participated in prior clinical trials
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
This study investigates the experiences of cancer patients with neuropathy during the COVID-19 pandemic to learn how the COVID-19 pandemic affects their quality of life and clinical outcomes. This study will also explore whether there are differences between patients who received neurofeedback (NFB, a type of therapy that is thought to help normalize brain activity) and those who did not. Learning about quality of life in cancer patients with neuropathy during the COVID-19 pandemic may help guide development of programs and policies to improve chronic pain patient care and outcomes during a major global healthcare crisis.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
COVID-19 Infection;Hematopoietic and Lymphoid Cell Neoplasm;Malignant Solid Neoplasm;Neuropathy
Study phase:
Physician name:
Sarah Prinsloo
Department:
Palliative Care & Rehabilitation Medicine
For general questions about clinical trials:
1-855-371-6974
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.